B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CHRM5

MOLECULAR TARGET

cholinergic receptor muscarinic 5

UniProt: P08912NCBI Gene: 113345 compounds

CHRM5 (cholinergic receptor muscarinic 5) is targeted by 45 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CHRM5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Hyoscyamine4.0959
2Arecoline3.6136
3Pilocarpine2.8917
4N-Methylscopolamine2.4811
5Hyoscyamine1.956
6Scopolamine1.956
7Muscarine1.614
8hexahydrosiladiphenidol1.393
9Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent1.102
10Fluoxetine0.691
11Mianserin0.691
12Quetiapine Fumarate0.691
13Ascorbic Acid0.691
14Amoxapine0.691
15Ascorbic Acid0.691
16Bisphenol A-Glycidyl Methacrylate0.691
17Butaclamol0.691
18Butylscopolammonium Bromide Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of0.691
19Chlorpheniramine0.691
20chlorprothixene hydrochloride0.691
21Cyclizine0.691
22Cyproheptadine0.691
23Dimethindene0.691
24Diphenhydramine0.691
25Guanabenz0.691
26Ipratropium0.691
27Loxapine0.691
28Loxapine0.691
29Maprotiline0.691
30mg6240.691
31Nicorandil0.691
32Nortriptyline0.691
33Nortriptyline0.691
34Perphenazine0.691
35Promazine0.691
36Promethazine0.691
37Propantheline0.691
38propionylpromazine hydrochloride0.691
39Salicylic Acid0.691
40Strychnine0.691
41Thioridazine0.691
42Tilorone0.691
43Tolterodine Tartrate0.691
44Triamcinolone0.691
45triflupromazine hydrochloride0.691

About CHRM5 as a Drug Target

CHRM5 (cholinergic receptor muscarinic 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 45 compounds with documented CHRM5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CHRM5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.